Skip to main content

Frailty

1
Pipeline Programs
11
Companies
7
Clinical Trials
2 recruiting
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
1
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

7 companies ranked by most advanced pipeline stage

Bayer
BayerLEVERKUSEN, Germany
1 program
1
Transdermal testosterone gelPhase 41 trial
Active Trials
NCT00190060Completed262Est. Dec 2008
Biosensics
BiosensicsMA - Newton
1 program
A Practical Platform for In-Home Remote Monitoring of Cognitive FrailtyN/A1 trial
Active Trials
NCT05754021Completed100Est. Jan 2025
A&D Medical
A&D MedicalMI - Ann Arbor
1 program
Breath Volatile Organic Compound AnalysisN/A1 trial
Active Trials
NCT06175429Unknown66Est. Dec 2025
Linnaeus Therapeutics
Linnaeus TherapeuticsNJ - Haddonfield
1 program
Health dialogueN/A1 trial
Active Trials
NCT07136168Recruiting2,952Est. Dec 2031
Forte Biosciences
1 program
Intervention group Case ManagerN/A1 trial
Active Trials
NCT06368674Recruiting150Est. Feb 2027
City Therapeutics
City TherapeuticsMA - Cambridge
1 program
Triage Assessment and NEWS-score as Risk Predictor in Older Frailty Adults in the EDN/A1 trial
Active Trials
NCT03783234CompletedEst. Oct 2020
Longeveron
LongeveronMIAMI, FL
1 program
Allogeneic Human Mesenchymal Stem CellsPHASE_1_21 trial
Active Trials
NCT02065245Completed65Est. Oct 2020

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
2031
BayerTransdermal testosterone gel
LongeveronAllogeneic Human Mesenchymal Stem Cells
Linnaeus TherapeuticsHealth dialogue
Forte BiosciencesIntervention group Case Manager
A&D MedicalBreath Volatile Organic Compound Analysis
BiosensicsA Practical Platform for In-Home Remote Monitoring of Cognitive Frailty
City TherapeuticsTriage Assessment and NEWS-score as Risk Predictor in Older Frailty Adults in the ED

Clinical Trials (7)

Total enrollment: 3,595 patients across 7 trials

NCT00190060BayerTransdermal testosterone gel

Study of The Effects of Testosterone in Frail Elderly Men

Start: Oct 2004Est. completion: Dec 2008262 patients
Phase 4Completed
NCT02065245LongeveronAllogeneic Human Mesenchymal Stem Cells

AllogeneiC Human Mesenchymal Stem Cells (hMSC) in Patients With Aging FRAilTy Via IntravenoUS Delivery

Start: Mar 2014Est. completion: Oct 202065 patients
Phase 1/2Completed
NCT07136168Linnaeus TherapeuticsHealth dialogue

Healthy Older Adults Through Movement and Engagement

Start: Aug 2025Est. completion: Dec 20312,952 patients
N/ARecruiting
NCT06368674Forte BiosciencesIntervention group Case Manager

Bridging the Gap: Creating a Continuum of Care

Start: Jun 2024Est. completion: Feb 2027150 patients
N/ARecruiting
NCT06175429A&D MedicalBreath Volatile Organic Compound Analysis

Prognostic Value of Exhaled Isoprene Levels for Morbidity and Functional Outcome in Cardiosurgical Patients

Start: Nov 2023Est. completion: Dec 202566 patients
N/AUnknown
NCT05754021BiosensicsA Practical Platform for In-Home Remote Monitoring of Cognitive Frailty

A Practical Platform for In-Home Remote Monitoring of Cognitive Frailty

Start: Feb 2022Est. completion: Jan 2025100 patients
N/ACompleted
NCT03783234City TherapeuticsTriage Assessment and NEWS-score as Risk Predictor in Older Frailty Adults in the ED

Triage Assessment and NEWS-score as Risk Predictor in Older Frailty Adults in the ED

Start: Dec 2018Est. completion: Oct 2020
N/ACompleted

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

2 actively recruiting trials targeting 3,595 patients
11 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.